Brain Resource offers pharmaceutical companies access to advanced resources and analysis tools that can dramatically improve their ability to bring better medications to market, sooner.
Brain Resource provides services to many of the world’s biggest pharmaceutical companies including Astra Zeneca, Merck, Eli Lilly and Johnson & Johnson.
Our 20+ years as a brain research organization and our work with Clinicians, Managed Care and the FDA make us an ideal partner in the pharmaceutical trial process. One standard for assessing brain function and cognition, used by all the key stakeholders, has the capacity to bring new insights and new efficiencies to the development of optimal solutions in Mental Health.
Why choose BRC methodology for your pharmaceutical trial?
Our range of standardized tests and access to our uniquely, large standardized and integrative database of the human brain, provide some very distinct advantages:
- Identify the best cognitive endpoints for your study. Determine which tests are the most important to use, their sensitivity and specificity. Determine optimal subject numbers needed to achieve targeted levels of statistical power in each trial
- Determine the suitability of the subjects themselves (how representative are they of the population you are assessing?) Our normative, clinical and drug databases can help you exclude inappropriate subjects from your trial so that you can trust the validity of your treatment effect.
- Standardization and automation streamlines the administration and speed of large scale testing over multiple test sites.
- You can choose from a wide range of behavioral and biological measures accross a variety of platforms to match the needs of your trial. Converging and complementary evidence from a range of brain function measures provide the most reliable confirmation of the efficacy of your compound.
- Tap into our Brain Resource International Database which allows us to identify the psychological and physiological factors that underpin the subtlest changes in cognition. Even if you choose to measure cognition alone, the Database provides crucial, value-added insights about the functional effect of your compound on cognition.
- Brain Resource is proud to have a range of psychologists, psychiatrists and clinical trial specialists in our network who are available to work with you to design your trial.
Pharmaceutical Trials Solutions:
Read more:
- Our methodology
- Test platforms for pharmaceutical trials
- Personalized Medicine
- Frequently Asked Questions
Additional presentations and papers:
-
BRC for Pharmaceutical Trials (PDF:1.9MB)
Key Markers (PDF: 790KB)
- Links between cognitive and biological markers (PDF: 1.96MB)
- Paper - The Dose-dependent effect of Methylphenidate on Performance, Cognition and Psychophysiology (PDF: 288KB)
For more information or to speak with a Pharmaceutical Trials representative: